Trulieve Cannabis
TRLV
10.78
+0.13
+1.22%
Trulieve Cannabis
US · TRLV
#2769 by market cap
Listed 1970
10.78
+0.13
+1.22%
Live - 5344 symbols - heartbeat 337s ago
· 2026-10-08 08:19
Pre-market
10.78
0.00%
After-hours
10.77
-0.09%
- Market cap
- 2.08B
- P/E (TTM)i
- -4.36
- P/Bi
- 2.71
- EPSi
- -0.61
- Div yieldi
- 0.00%
- 52W posi
- 71%
Reader sentiment
Are you bullish or bearish on TRLV?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.14, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -0.45% YoY
Margins
- Gross margin
- 60.21%
- Operating margin
- 12.56%
- Net margin
- -9.85%
Key ratios & quality
- Enterprise valuei
- 2.08B
- Altman Z-Scorei
- 1.14
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 102.82M | 252.82M | 521.53M | 931.93M | 1.22B | 1.13B | 1.19B | 1.18B |
| Gross profit | 80.43M | 191.84M | 386.42M | 566.57M | 689.13M | 588.63M | 715.75M | 711.17M |
| Selling & admin expenses | 44.21M | 73.42M | 155.45M | 311.36M | 447.03M | 386.16M | 510.45M | 445.21M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 35.09M | 113.34M | 218.37M | 209.42M | 125.71M | 92.64M | 92.49M | 148.32M |
| Pretax profit | 33.04M | 103.68M | 157.45M | 176.25M | -19.24M | -284.54M | 42.71M | 91.47M |
| Tax | 22.15M | 50.59M | 94.45M | 145.72M | 163.38M | 151.36M | 197.59M | 208.11M |
| Net profit | 10.89M | 53.10M | 63.00M | 17.45M | -252.73M | -533.14M | -160.58M | -122.25M |
| Basic EPS | 0 | 0 | 1 | 0 | -1 | -3 | -1 | -1 |
| Diluted EPS | 0.11 | 0.46 | 0.53 | 0.12 | -1.31 | -2.79 | -0.82 | -0.61 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 297.76M | 302.09M | 288.19M | 293.15M | 286.75M | 270.95M |
| Gross profit | 183.22M | 182.93M | 169.86M | 175.17M | 170.08M | 162.29M |
| Selling & admin expenses | 118.77M | 101.12M | 99.02M | 126.31M | 104.90M | 101.77M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 35.12M | 52.38M | 41.38M | 19.44M | 35.44M | 34.80M |
| Pretax profit | 20.33M | 38.90M | 29.30M | 2.94M | 25.22M | -383.40M |
| Tax | 52.46M | 54.72M | 53.04M | 47.89M | 21.86M | 21.97M |
| Net profit | -33.76M | -16.11M | -28.78M | -43.59M | 2.28M | -406.06M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | -2 |
| Diluted EPS | -0.17 | -0.07 | -0.14 | -0.22 | 0.01 | -2.10 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 80.79M | 165.47M | 261.45M | 524.42M | 593.54M | 477.35M | 604.56M | 562.72M |
| Cash & ST investments | 24.43M | 91.81M | 146.71M | 230.65M | 207.19M | 201.37M | 299.20M | 255.54M |
| Inventory | 53.91M | 65.98M | 98.31M | 212.19M | 276.51M | 213.12M | 231.37M | 242.30M |
| Total assets | 162.07M | 386.00M | 809.78M | 3.41B | 3.40B | 2.73B | 2.87B | 2.70B |
| Total current liabilities | 34.71M | 52.67M | 76.12M | 168.94M | 210.30M | 114.85M | 138.49M | 126.95M |
| Short-term debt | 7.76M | 7.74M | 21.17M | 27.07M | 32.20M | 22.93M | 26.99M | 30.24M |
| Long-term debt | 12.65M | 15.98M | 121.17M | 469.39M | 635.91M | 479.07M | 476.78M | 227.58M |
| Total liabilities | 57,853,450.00 | 253,113,000.00 | 361,873,000.00 | 1,263,499,000.00 | 1,472,701,000.00 | 1,320,442,000.00 | 1,621,238,000.00 | 1,553,089,000.00 |
| Total equity | 104.22M | 132.88M | 447.90M | 2.15B | 1.93B | 1.41B | 1.25B | 1.14B |
| Retained earnings | 27.61M | 56.69M | 119.69M | 137.72M | -113.84M | -640.64M | -795.74M | -912.13M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 649.38M | 711.38M | 756.45M | 562.72M | 652.96M | 564.83M |
| Cash & ST investments | 328.45M | 392.58M | 449.20M | 255.54M | 352.88M | 325.42M |
| Inventory | 239.28M | 241.46M | 243.29M | 242.30M | 242.32M | 186.87M |
| Total assets | 2.89B | 2.92B | 2.94B | 2.70B | 2.78B | 2.08B |
| Total current liabilities | 136.67M | 123.84M | 124.13M | 126.95M | 124.16M | 95.06M |
| Short-term debt | 27.75M | 28.71M | 29.23M | 30.24M | 31.17M | 26.24M |
| Long-term debt | 476.40M | 474.20M | 473.79M | 227.58M | 285.74M | 285.21M |
| Total liabilities | 1,668,764,000.00 | 1,712,364,000.00 | 1,755,342,000.00 | 1,553,089,000.00 | 1,632,618,000.00 | 1,311,527,000.00 |
| Total equity | 1.22B | 1.21B | 1.19B | 1.14B | 1.15B | 765.91M |
| Retained earnings | -828.61M | -842.39M | -869.23M | -912.13M | -909.72M | -1.32B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 23.52M | 19.07M | 99.64M | 12.90M | 23.10M | 201.84M | 271.48M | 272.82M |
| Depreciation & amortization | 3.11M | 15.80M | 30.19M | 78.22M | 185.57M | 170.66M | 166.37M | 173.40M |
| Free cash flow | -20.02M | -55.80M | -47.10M | -296.93M | -170.70M | 150.99M | 123.82M | 212.31M |
| Dividends paid | -- | -- | -- | 0 | -- | -- | -- | -- |
| Stock buybacks / issuance | 47.47M | 0 | 83.23M | 217.90M | -- | 0 | 0 | 140.00M |
| Ending cash balance | 24.43M | 91.81M | 146.71M | 229.64M | 213.79M | 207.98M | 239.71M | 255.54M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 51.13M | 86.10M | 76.38M | 59.22M | 55.71M | 53.14M |
| Depreciation & amortization | 43.18M | 43.15M | 43.41M | 43.67M | 43.73M | 39.15M |
| Free cash flow | 30.33M | 70.08M | 59.66M | 52.23M | 42.22M | 32.13M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 329.36M | 400.99M | 457.61M | 255.54M | 352.88M | 325.42M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 82.68 | 92.11 | 17.25 | 1.39 | -12.07 | -31.49 | -11.59 | -9.61 |
| ROA %i | 52.99 | 47.29 | 8.96 | 0.85 | -7.23 | -17.19 | -5.54 | -4.18 |
| ROIC %i | 60.66 | 60.93 | 14.10 | 2.40 | -6.14 | -18.08 | -5.48 | -4.08 |
| 5-year avg ROE %i | -- | -- | -- | -- | 15.35 | 4.86 | -6.41 | -12.67 |
| EBIT margin %i | 71.89 | 112.84 | 34.07 | 21.13 | 2.94 | -17.97 | 8.84 | 13.12 |
| FCF / sales %i | -- | -- | -- | -- | -- | 12.96 | 9.85 | 17.97 |
| Current ratioi | 2.33 | 3.14 | 3.43 | 3.10 | 2.82 | 4.16 | 4.37 | 4.43 |
| Quick ratioi | 0.70 | 1.74 | 1.95 | 1.48 | 1.02 | 1.87 | 2.33 | 2.17 |
| Debt / assetsi | 12.97 | 21.88 | 35.51 | 25.18 | 28.67 | 29.04 | 28.72 | 20.91 |
| LT debt / equityi | 12.73 | 57.72 | 59.47 | 38.77 | 48.82 | 54.41 | 63.23 | 45.93 |
| Interest coveragei | 33.85 | 22.26 | 8.78 | 5.70 | 0.46 | -2.49 | 1.69 | 2.44 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 108.50 | 68.90 | 29.37 | 8.38 | -1.02 |
| Net income CAGR (3Y) %i | -- | -- | -- | 18.29 | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -12.58 | -12.79 | -9.69 | -9.61 | -6.76 | -47.51 |
| ROA %i | -5.78 | -5.76 | -4.19 | -4.18 | -2.86 | -18.93 |
| ROIC %i | -5.94 | -5.99 | -4.01 | -4.08 | -2.77 | -26.36 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 8.00 | 8.29 | 11.69 | 13.12 | 13.40 | -23.62 |
| FCF / sales %i | 2.37 | 5.06 | 11.93 | 17.97 | 19.16 | 16.35 |
| Current ratioi | 4.75 | 5.74 | 6.09 | 4.43 | 5.26 | 5.94 |
| Quick ratioi | 2.57 | 3.34 | 3.78 | 2.17 | 3.02 | 3.71 |
| Debt / assetsi | 28.53 | 28.19 | 27.64 | 20.91 | 22.60 | 27.79 |
| LT debt / equityi | 64.61 | 64.89 | 65.11 | 45.93 | 51.17 | 71.80 |
| Interest coveragei | 1.49 | 1.52 | 2.19 | 2.44 | 2.59 | -4.73 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 08:19:27 · For reference only, not investment advice and not tailored to your situation.